Decreased platelet cytochrome c oxidase activity is accompanied by increased blood lactate concentration during exercise in patients with Alzheimer disease

Experimental Neurology

Volumn 182, Issue 2, 2003, Pages 421-426

  Mancuso, Michelangelo ^a   Filosto, Massimiliano ^b   Bosetti, Francesca ^c,d   Ceravolo, Roberto ^a   Rocchi, Anna ^a   Tognoni, Gloria ^a   Manca, Maria Laura ^a   Solaini, Giancarlo ^b   Siciliano, Gabriele ^a   Murri, Luigi ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF VERONA   (Italy)

^c SCUOLA SUPERIORE SANT ANNA   (Italy)

^d NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

Alzheimer's disease; Cytochrome c oxidase; Exercise; Lactate; Mitochondria; Platelets

Indexed keywords

CYTOCHROME C OXIDASE; LACTIC ACID;

ADULT; AGED; ALZHEIMER DISEASE; ANAEROBIC METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; ENZYME ACTIVITY; EXERCISE; FEMALE; FOREARM; FUNCTIONAL ASSESSMENT; HUMAN; LACTATE BLOOD LEVEL; MALE; MONITORING; MUSCLE CONTRACTION; PATIENT; PRIORITY JOURNAL; PROTEIN ANALYSIS; REST; THROMBOCYTE; VOLUNTARY MOVEMENT;

EID: 0043166643     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-4886(03)00092-X     Document Type: Article

References (49)

1. Albers D.S., Beal M.F. Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J. Neural. Transm. 59:(Suppl.):2000;133-154.
2. American Psychiatric Association, 1994. Diagnostic and Statistic Manual of Mental Disorders, American Psychiatric Association, Washington, DC. 4th ed., pp. 142-143.
3. Baracca A., Barogi S., Carelli V., Lenaz G., Solaini G. Catalytic activities of mitochondrial ATP synthase in patients with mitochondrial DNA T8993G mutation in the ATPase 6 gene encoding subunit a. J. Biol. Chem. 275:2000;4177-4182.
4. Beal M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neu. 31:1992;119-130.
5. Blass J.P., Gibson G.E. The role of oxidative abnormalities in the pathophysiology of Alzheimer's disease. Rev Neurol. 147:1991;513-525.
6. Bonilla E., Tanji K., Hirano M., Vu T.H., DiMauro S., Schon E.A. Mitochondrial involvement in Alzheimer's disease. Biochim. Biophys. Acta. 1410:1999;171-182.
7. Borthwick G.M., Johnson M.A., Ince P.G., Shaw P.J., Turnbull D.M. Mitochondrial enzyme activity in amyotrophic lateral sclerosis implications for the role of mitochondria in neuronal cell death . Ann. Neurol. 46:1999;787-790.
8. Bosetti F., Brizzi F., Barogi S., Mancuso M., Siciliano G., Tendi E.A., Murri L., Rapoport S.L., Solaini G. Cytochrome c oxidase and mitochondrial F1F0- ATPase (ATP synthase) activities in platelets and brain from patients with Alzheimer's disease. Neurobiol. Aging. 23:2002;371-376.
9. Bowen D.M., White P., Spillane J.A., Goodhardt M.J., Curzon G., Iwangoff P., Meier-Ruge W., Davison A.N. Accelerated ageing or selective neuronal loss as an important cause of dementia? Lancet. 1:1979;11-14.
10. Bradford M.M. A refined and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Ann. Biochem. 72:1976;248-254.
11. Casley C.S., Canevari L., Land J.M., Clark J.B., Sharpe M.A. Beta amyloid inhibts integrated mitochondrial respiration and key enzyme activities. J. Neurochem. 80:2002;91-100.
12. Cassarino D.S., Bennett J.P. Jr. An evaluation of the role of mitochondria in neurodegenerative diseases mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration . Brain Res. Rev. 29:1999;1-25.
13. Chandrasekaran K., Hatanpaa K., Brady D.R., Rapoport S.I. Evidence for physiological down-regulation of brain oxidative phosphorylation in Alzheimer's disease. Exp. Neurol. 142:1996;80-88.
14. Duara R., Lopez-Alberola R.F., Barker W.W., Loewenstein D.A., Zatinsky M., Eisdorfer C.E., Weinberg G.B. A comparison of familial and sporadic Alzheimer's disease. Neurology. 43:1993;1377-1384.
15. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state"; a practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
16. Green D.R., Read J.C. Mitochondria and apoptosis. Science. 281:1998;1309-1312.
17. Hachinski V.C., Iliff L.D., Zilhka E., Du Boulay G.H., McAllister V.L., Marshall J., Russell R.W., Symon L.E. Cerebral blood flow in dementia. Arch. Neurol. 32:1975;632-637.
18. Kindermann W., Simon G., Keul J. The significance of the aerobic-anaerobic transition for the determination of workload intensities during endurance training. Eur. J. Appl. Physiol. 42:1979;25-34.
19. Kish S.J., Bergeron C., Rajput A., Dozic S., Mastrogiacomo F., Chang L.J., Wilson J.M., DiStefano L.M., Nobrega J.N. Brain cytochrome oxidase in Alzheimer's disease. J. Neurochem. 59:1992;776-779.
20. Marcus D.L., de Leon M.J., Goldman J., Logan J., Christman D.R., Wolf A.P., Fowler J.S., Hunter K., Tsai J., Pearson J., et al. Altered glucose metabolism in microvessels from patients with Alzheimer's disease. Ann. Neurol. 26:1989;91-94.
21. Mariani C., Bresolin N., Farina E., Moggio M., Ferrante C., Ciafaloni E., Sertorelli S., Ciccone A., Scarlato G. Muscle biopsy in Alzheimer's disease morphological and biochemical findings . Clin. Neuropathol. 10:1991;171-176.
22. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
23. Maurer I., Zierz S., Möller H.-J. A selective defect of cytochrome c oxidase is present in brain of Alzheimer disease patients. Neurobiol. Aging. 21:2000;455-462.
24. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease . Neurology. 34:1984;939-944.
25. Mudher A., Lovestone S. Alzheimer's disease - do tauists and baptists finally shake hands? Trends Neurosci. 25:2000;22-26.
26. Mutisya E.M., Bowling A.C., Beal M.F. Cortical cytochrome oxidase activity is reduced in Alzheimer's disease. J. Neurochem. 63:1994;2179-2184.
27. Nashef L., Lane R.J. Screening for mitochondrial cytopathies the sub-anaerobic threshold exercise test (SATET) . J. Neurol. Neurosurg. Psychiat. 52:1989;1090-1094.
28. Parker W.D. Jr., Mahr N.J., Filley C.M., Parks J.K., Hughes D., Young D.A., Cullum C.M. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology. 44:1994;1086-1090.
29. Parker W.D. Jr., Filley C.M., Parks J.K. Cytochrome oxidase deficiency in Alzheimer's disease. Neurology. 40:1990;1302-1303.
30. Parker W.D. Jr., Boyson S.J., Luder A.S., Parks J.K. Evidence for a defect in NADH ubiquinone oxidoreductase (complex I) in Huntington's disease . Neurology. 40:1990;1231-1234.
31. Parnetti L., Reboldi G.P., Gallai V. Cerebrospinal fluid pyruvate levels in Alzheimer's disease and vascular dementia. Neurology. 54:2000;735-737.
32. Peterson C., Goldman J.E. Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Natl. Acad. Sci. USA. 83:1986;2758-2762.
33. Raha S., Robinson B.H. Mitochondria, oxygen free radicals and apoptosis. Am. J. Med. Genet. 106:2001;62-70.
34. Redjems-Bennani N., Jeandel C., Lefebvre E., Blain H., Vidailhet M., Gueant J.L. Abnormal substrate levels that depend upon mitochondrial function in cerebrospinal fluid from Alzheimer patients. Gerontology. 44:1998;300-304.
35. Reisberg B., Ferris S., Shulman E. The Global Deterioration Scale for the assesment of primary progressive dementia. Am. J. Psychiat. 139:1982;1136-1139.
36. Rocha L., De Mendoca A., Garcia C., Lechner M.C. Apoliporpotein E genotype of a Portuguese control population and Alzheimer's disease patients. Eur. J. Neurol. 4:1997;448-452.
37. Schapira A.H. Mitochondrial involvement in Parkinson's disease, Huntington's disease, hereditary spastic paraplegia and Friedreich's ataxia. Biochim. Biophys. Acta. 1410:1999;159-170.
38. Schapira A.H. Oxidative stress and mitochondrial dysfunction in neurodegeneration. Curr. Opin. Neurol. 9:1996;260-264.
39. Shepherd D., Garland P.B. The kinetic properties of citrate synthase from rat liver mitochondria. Biochem. J. 114:1969;597-610.
40. Siciliano G., Rossi B., Manca L., Angelini C., Tessa A., Vergani L., Martinuzzi A., Muratorio A. Residual muscle cytochrome c oxidase activity accounts for submaximal exercise lactate threshold in chronic progressive external ophthalmoplegia. Muscle Nerve. 19:1996;342-349.
41. Simonian N.A., Hyman B.T. Functional alterations in Alzheimer's disease diminution of cytochrome oxidase in the hippocampal formation . J. Neuropathol. Exp. Neurol. 52:1993;580-585.
42. Simonian N.A., Hyman B.T. Functional alterations in Alzheimer's disease selective loss of mitochondrial-encoded cytochrome oxidase mRNA in the hippocampal formation . J. Neuropathol. Exp. Neurol. 53:1994;508-512.
43. Skulachev V.P. Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductans. Q. Rev. Biophys. 29:1996;696-699.
44. Wallace D.C. Mitochondrial genetics a paradigm for aging and degenerative diseases? Science. 25:1992;628-632.
45. Ware J.E. Jr. SF-36 health survey update. Spine. 25:2000;3130-3139.
46. Wasserman K., Whipp B.J., Koyal S.N., Beaver W.L. Anaerobic threshold and respiratory gas exchange during exercise. J. Appl. Physiol. 35:1973;236-243.
47. Wharton D.C., Tzagoloff A. Cytochrome oxidase from beef heart mitochondria. Methods Enzymol. 10:1967;245-250.
48. Wiedemann F.R., Vielhaber S., Schroder R., Elger C.E., Kunz W.S. Evaluation of methods for determination of mitochondrial respiratory chain enzyme activities in human skeletal muscle samples. Anal. Biochem. 279:2000;55-60.
49. Wong-Riley M.T. Cytochrome oxidase an endogenous metabolic marker for neuronal activity . Trends Neurosci. 12:1989;94-101.